Agios Pharmaceuticals, Inc. (AGIO) - NASDAQ
Company Description
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in cellular metabolism to transform the lives of patients with cancer and rare genetic disorders of metabolism, or RGDs, which are a subset of rare genetic diseases. The company's products include IDH1 AND IDH2, PKR, II D-2... More
Sector: Healthcare
Industry: Biotechnology
Country: United States